Meitav Investment House’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-244,332
| Closed | -$494K | – | 544 |
|
|
2023
Q1 | $494K | Sell |
244,332
-150
| -0.1% | -$303 | 0.01% | 289 |
|
|
2022
Q4 | $319K | Buy |
244,482
+150
| +0.1% | +$196 | 0.01% | 319 |
|
|
2022
Q3 | $256K | Hold |
244,332
| – | – | ﹤0.01% | 335 |
|
|
2022
Q2 | $264K | Hold |
244,332
| – | – | ﹤0.01% | 310 |
|
|
2022
Q1 | $257K | Buy |
+244,332
| New | +$257K | ﹤0.01% | 353 |
|
|
2021
Q4 | – | Sell |
-244,332
| Closed | -$325K | – | 405 |
|
|
2021
Q3 | $325K | Hold |
244,332
| – | – | 0.01% | 346 |
|
|
2021
Q2 | $467K | Buy |
+244,332
| New | +$467K | 0.01% | 318 |
|
|
2019
Q4 | – | Sell |
-6,136
| Closed | -$13K | – | 466 |
|
|
2019
Q3 | $13K | Sell |
6,136
-6,570
| -52% | -$13.9K | ﹤0.01% | 439 |
|
|
2019
Q2 | $60K | Hold |
12,706
| – | – | ﹤0.01% | 425 |
|
|
2019
Q1 | $55K | Hold |
12,706
| – | – | ﹤0.01% | 383 |
|
|
2018
Q4 | $39K | Hold |
12,706
| – | – | ﹤0.01% | 331 |
|
|
2018
Q3 | $91K | Buy |
12,706
+6,570
| +107% | +$47.1K | ﹤0.01% | 432 |
|
|
2018
Q2 | $28K | Sell |
6,136
-6,570
| -52% | -$30K | ﹤0.01% | 420 |
|
|
2018
Q1 | $68K | Hold |
12,706
| – | – | ﹤0.01% | 328 |
|
|
2017
Q4 | $85K | Buy |
+12,706
| New | +$85K | 0.01% | 198 |
|